Surprisingly, the administration of Dexamethasone onto exacerbated, but not stable, COPD-derived PBMCs was not able to abolish AIM2-dependent IL-1α release, implying that corticosteroids treatment does not influence AIM2-dependent inflammatory signaling. Here, AIM2 is linked to chronic obstructive pulmonary disease.